Mitochondrial respiratory enzymes are a major target of iron toxicity in rat heart cells

Journal of Laboratory and Clinical Medicine

Volumn 131, Issue 5, 1998, Pages 466-474

  Link, Gabriela ^b   Saada, Ann ^b   Pinson, Arie ^b   Konijn, Abraham M ^b   Hershko, Chaim ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032078224     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90148-2     Document Type: Article

References (52)

1. Gabutti V, Borgna-Pignatti C. Clinical manifestations and therapy of transfusional haemosiderosis. Clin Haematol 1996;7:919-40.
2. Moreb J, Hershko C, Hasin Y. Effects of acute iron loading on contractility and spontaneous beating rate of cultured rat myocardial cells. Basic Res Cardiol 1988;83:360-8.
3. Link G, Athias P, Grynberg A, Pinson A, Hershko C. Effect of iron loading on transmembrane potential, contraction and automaticity of rat ventricular muscle cells in culture. J Lab Clin Med 1989;113:103-11.
4. Link G, Pinson A, Hershko C. Heart cells in culture: a model of myocardial iron overload and chelation. J Lab Clin Med 1985;106:147-53.
5. Hershko C, Link G, Pinson A. Modification of iron uptake and lipid peroxidation by hypoxia, ascorbic acid, and α-tocopherol in iron-loaded rat myocardial cell cultures. J Lab Clin Med 1987;110:355-61.
6. Link G, Pinson A, Kahane I, Hershko C. Iron loading modifies the fatty acid composition of cultured rat myocardial cells and liposomal vesicles: effect of ascorbate and α-tocopherol on myocardial lipid peroxidation. J Lab Clin Med 1989;114:243-9.
7. Hershko C, Link G, Pinson A, Peter HH, Dobbin P, Hider RC. Iron mobilization from myocardial cells by 3-hydroxypyridin-4-one chelators: studies in rat heart cells in culture. Blood 1991;77:2049-53.
8. Link G, Athias P, Grynberg A, Hershko C, Pinson A. Iron loading modifies β-adrenergic responsiveness of cultured ventricular myocytes. Cardioscience 1991;2:27-30.
9. Link G, Pinson A, Hershko C. Iron loading of cultured cardiac myocytes modifies sarcolemmal structure and increases lysosomal fragility. J Lab Clin Med 1993;121:127-34.
10. Link G, Pinson A, Hershko C. The ability of orally effective iron chelators dimethyl- and diethyl-hydroxypyrid-4-one and of deferoxamine to restore sarcolemmal thiolic enzyme activity in iron-loaded heart cells. Blood 1994;83:2692-7.
11. Richter C, Gogvadze V, Laffranchi R, et al. Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta 1995;1271:67-74.
12. Bacon BR, O'Neill R, Britton RS. Hepatic mitochondrial energy production in rats with chronic iron overload. Gastroenterology 1993;105:1134-40.
13. Ceccarelli D, Gallesi D, Giovannini F, Ferrali M, Masini A. Relationship between free iron level and rat liver mitochondrial dysfunction in experimental dietary iron overload. Biochem Biophys Res Comm 1995;209:53-9.
14. Link G, Tirosh R, Pinson A, Hershko C. Role of iron in the potentiation of anthracycline toxicity: identification of heart cell mitochondria as the site of iron-anthracycline interaction. J Lab Clin Med 1996;127:272-8.
15. Iancu TC, Shiloh H, Link G, Bauminger ER, Pinson A, Hershko C. Ultrastructural pathology of iron loaded rat myocardial cells in culture. Br J Exp Pathol 1987;68:53-65.
16. Bauminger ER, Iancu TC, Link G, Pinson A, Hershko C. Iron overload in cultured rat myocardial cells. Hyperfine Interact 1987;33:249-62.
17. Mode EB. Elements of statistics. 3rd ed. Englewood Cliffs, NJ: Prentice-Hall, 1961.
18. Hall RE, Henriksson KG, Lewis SF, Haller R, Kennaway NG. Mitochondrial myopathy with succinate dehydrogenase and aconitase deficiency: abnormalities of several iron-sulfur proteins. J Clin Invest 1993;92:2660-6.
19. Singer TP. Determination of the activity of succinate, NADH, choline and α-glycerophosphate dehydrogenases. In: Glick D, editor. Methods of biochemical analysis (vol 22). New York: Interscience, 1974:123-75.
20. Sottocasa GL, Kuylenstierna B, Ernster L, Bergstrand A. An electron transport system associated with the outer membrane of liver mitochondria. J Cell Biol 1967;32:415-38.
21. Trumpower BL, Edwards CA. Purification of a reconstitutively active iron sulfur protein (oxidation factor) from succinate-cytochrome c reductase complex of bovine heart mitochondria. J Biol Chem 1979;254:8697-706.
22. Hatefi Y, Stigall DL. Preparation and properties of succinate: ubiquinone oxidoreductase (complex II). In: Fleisher S, Packer L, editors. Methods in enzymology. New York: Academic Press, 1978;53:21-7.
23. Fisher JC, Ruitenbeek W, Trijbels JMF, et al. Estimation of NADH oxidation in human skeletal muscle mitochondria. Clin Chim Acta 1986;155:263-74.
24. Birch-Machin MA, Briggs HL, Sasorido AA, Bindoff LA, Turnbull DM. An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria. Biochem Med Metabol Biol 1994;51:35-42.
25. Wharton DC, Tzagaloff A. Cytochrome C oxidase from beef heart mitochondria. In: Estabrook RW, Pullman MF, editors. Methods in enzymology. New York: Academic Press, 1967;10:245-6.
26. Srere PA. Citrate synthase. In: Lowenstein JM, editor. Methods in enzymology. New York: Academic Press, 1969;13:3-11.
27. Holmsen H, Storm E, Day HG. Determination of ATP and ADP in blood platelets: a modification of the firefly luciferase assay for plasma. Anal Biochem 1972;46:489-509.
28. Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: an overview. In: Packer L, Glazer AN, editors. Methods in enzymology. New York: Academic Press, 1990;186:1-85.
29. Metal chelation therapy, oxygen radicals, and human disease [editorial]. Lancet 1985; 1:143.
30. Stadtman ER. Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic Biol Med 1990;9:315-25.
31. Goddard JG, Sweeney GD. Ferric nitriloacetate: a potent stimulant of in vivo lipid peroxidation in mice. Biochem Pharmacol 1983;32:3879-82.
32. Dillard CJ, Downey JE, Tappel AL. Effect of antioxidants on lipid peroxidation in iron-loaded rats. Lipids 1984;19:127-33.
33. Mak IT, Weglicki WB. Characterization of iron-mediated peroxidative injury in isolated hepatic lysosomes. J Clin Invest 1985;75:58-63.
34. Seymour CA, Peters TJ. Organelle pathology in primary and secondary hemochromatosis with special reference to lysosomal changes. Br J Haematol 1978;40:239-53.
35. Houglum K, Filip M, Witztum JL, Choikier M. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J Clin Invest 1990;86:1991-8.
36. Schauenstein E, Esterbauer H, Zollner H. Aldehydes in biological systems. London: Pion Limited, 1977:102.
37. Robinson BH, Glerum DM, Chow W, Petrova-Benedict R, Lightowlers R, Capaldi R. The use of skin fibroblast cultures in the detection of respiratory chain defects in patients with lactic acidemia. Pediatr Res 1990;28:549-55.
38. Hatefi Y. Preparation and properties of NADH:ubiquinone oxidoreductase (complex I) ECI6.5.3. In: Fleisher S, Packer L, editors. Methods in enzymology. New York: Academic Press, 1978;53:11-4.
39. Zhang Y, Marcillat O, Giulivi C, Ernster L, Davies KJ. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem 1990;265: 16330-6.
40. Kadiiska MB, Burkitt MJ, Qun-Hui Xiang, Mason RP. Iron supplementation generates hydroxyl radical in vivo: an ESR spin-trapping investigation. J Clin Invest 1995;96:1653-7.
41. Fry M, Green DE. Cardiolipin requirement by cytochrome oxidase and the catalytic role of phospholipid. Biochem Biophys Res Commun 1980;93:1238-46.
42. Goormaghtigh E, Brasseur R, Ruysschaert JM. Adriamycin inactivates cytochrome c oxidase by exclusion of the enzyme from its cardiolipin essential environment. Biochem Biophys Res Commun 1982;104:314-20.
43. Heales SJR, Davies SEC, Bates TE, Clark JB. Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration. Neurochem Res 1995;20:31-8.
44. Zager A. Mitochondrial free radical production induces lipid peroxidation during myohemoglobinuria. Kidney Int 1996;49:741-51.
45. Pitkainen S, Robinson BH. Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J Clin Invest 1996;98:345-51.
46. Reynolds LG. Diagnosis and management of acute iron poisoning. Clin Haematol 1989;2:423-34.
47. Hershko C, Weatherall DJ. Iron chelating therapy. Crit Rev Clin Lab Sci 1988;26:303-45.
48. Olson RD, Mushlin PS. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J 1990;4:3076-86.
49. Singal PK, Deally CMR, Weinberg LE. Subcellular effects of adriamycin in the heart: a concise review. J Mol Cell Cardiol 1987;19:817-28.
50. Povis G. Free radical formation by antitumor quinones. Free Radic Biol Med 1989;6:63-101.
51. Lederman HM, Cohen A, Lee JWJ, Freedman MH, Gelfand EW. Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation. Blood 1984;64:748-53.
52. Hoffbrand AV, Ganeshaguru K, Hooton JWL, Tattersall MHN. Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells. Br J Haematol 1976;33:517-26.